Document Detail

Human Sgo1 is an excellent target for induction of apoptosis of transformed cells.
MedLine Citation:
PMID:  16628005     Owner:  NLM     Status:  MEDLINE    
Aneuploidy, a frequent form of genomic instability, is a direct result of mis-segregation of sister chromatids during mitosis. Cohesion of sister chromatids in eukaryotes is primarily achieved by the cohesin complex. Since Sgo1 functions to protect centromeric cohesin and since depletion of Sgo1 results in precocious chromosomal segregation and massive mitotic arrest, we reasoned that disruption of Sgo1 functions by delivery of a competitive peptide could interfere with normal cell cycle progression. Treatment of HeLa and A549 cells with a Sgo1 fragment of 22 amino acids (corresponding to a conserved basic region at the C-terminus) linked with a cell-permeable peptide penetratin, but not with penetratin alone, resulted in concentration-dependent suppression of viability. Following 24 h treatment with Sgo1 peptide at a 40 muM final concentration, HeLa cell viability was dramatically reduced. The Sgo1 peptide induced rapid and drastic changes of cell and nuclear morphologies, which were associated with disappearance of cellular Sgo1 at kinetochores in mitotic cells. Moreover, the reduction in HeLa cell viability after treatment with Sgo1 peptide resulted from induction of apoptosis. Interestingly, WI-38 diploid fibroblasts were rather resistant to the treatment with Sgo1 peptide. These normal cells exhibited little changes of cellular and nuclear morphologies, and remained viable after exposure to 40 muM of Sgo1 peptide for 24 h. Our combined studies thus suggest that small peptides corresponding to conserved regions of Sgo1 are capable of functioning as dominant negative inhibitors in vivo and that Sgo1 is an excellent target for induction of apoptosis of cancer cells.
Yali Yang; Xiaoxing Wang; Wei Dai
Related Documents :
19180585 - Outcome of treatment of human hela cervical cancer cells with roscovitine strongly depe...
20650225 - Comparative evaluation of the susceptibility of neuronal (n1e-115) and non-neuronal (he...
18022825 - A combined treatment of hela cells with the farnesyl protein transferase inhibitor l-74...
7118295 - The role of differentiation in the suppression of tumorigenicity in human cell hybrids.
19144315 - T cell adhesion primes antigen receptor-induced calcium responses through a transient r...
11699865 - Responses of epithelial and fibroblast-like cells to discontinuous configuration of the...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2006-04-17
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  5     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-05-11     Completed Date:  2006-08-09     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  896-901     Citation Subset:  IM    
Institute of Health Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amino Acid Sequence
Cell Cycle Proteins / physiology*
Cell Line, Transformed
Cell Line, Tumor
Cell Survival
Fibroblasts / metabolism
Hela Cells
Molecular Sequence Data
Peptides / chemistry
Protein Structure, Tertiary
Sequence Homology, Amino Acid
Grant Support
Reg. No./Substance:
0/Cell Cycle Proteins; 0/Peptides; 0/SGOL1 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  M-phase MELK activity is regulated by MPF and MAPK.
Next Document:  2-deoxy-D-glucose reduces the level of constitutive activation of ATM and phosphorylation of histone...